EWA
PRAX icon

Evolution Wealth Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Evolution Wealth Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17
Closed -$5K – 509
2021
Q3 		$5K Sell
17
-26
-60% -$7.05K ﹤0.01% 520
2021
Q2 		$12K Buy
43
+28
+187% +$10K ﹤0.01% 384
2021
Q1 		$7K Buy
15
+4
+36% +$2.84K ﹤0.01% 484
2020
Q4 		$9K Buy
+11
New +$6.42K ﹤0.01% 365

Other funds holding PRAX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Evolution Wealth Advisors's PRAX Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Praxis Precision Medicines (PRAX) in Q4 2021, closing a stake of 17 shares — an estimated $5K sold.

Evolution Wealth Advisors first reported a position in PRAX in Q4 2020 and held it in 4 quarters. The position peaked at $12K in Q2 2021. 100 funds tracked by Wall St. Rank hold PRAX as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Praxis Precision Medicines position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 17 Praxis Precision Medicines shares in Q4 2021, an estimated $5K.
  • Evolution Wealth Advisors first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 4 quarters.
  • Evolution Wealth Advisors's Praxis Precision Medicines position peaked at $12K in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.